These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36923215)

  • 41. A Cuproptosis-Related lncRNAs Signature Could Accurately Predict Prognosis in Patients with Clear Cell Renal Cell Carcinoma.
    Zhang W; Wang H; Wang W; Xue H; Qiao M; Song L; Wang S; Ren Z; Ma Z
    Anal Cell Pathol (Amst); 2022; 2022():4673514. PubMed ID: 36588797
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular characterization of papillary thyroid carcinoma: a potential three-lncRNA prognostic signature.
    You X; Yang S; Sui J; Wu W; Liu T; Xu S; Cheng Y; Kong X; Liang G; Yao Y
    Cancer Manag Res; 2018; 10():4297-4310. PubMed ID: 30349364
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Novel Glycolysis-Related Long Noncoding RNA Signature for Predicting Overall Survival in Gastric Cancer.
    Zeng J; Li M; Dai K; Zuo B; Guo J; Zang L
    Pathol Oncol Res; 2022; 28():1610643. PubMed ID: 36419649
    [No Abstract]   [Full Text] [Related]  

  • 44. Identification of potential LncRNAs as papillary thyroid carcinoma biomarkers based on integrated bioinformatics analysis using TCGA and RNA sequencing data.
    Feng JL; Zheng WJ; Xu L; Zhou QY; Chen J
    Sci Rep; 2023 Mar; 13(1):4350. PubMed ID: 36928327
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Establishment of a prognostic signature for lung adenocarcinoma using cuproptosis-related lncRNAs.
    Yalimaimaiti S; Liang X; Zhao H; Dou H; Liu W; Yang Y; Ning L
    BMC Bioinformatics; 2023 Mar; 24(1):81. PubMed ID: 36879187
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Potential Four-Gene Signature and Nomogram for Predicting the Overall Survival of Papillary Thyroid Cancer.
    Ding Y; Li P; Wang W; Liu F
    Dis Markers; 2022; 2022():8735551. PubMed ID: 36193505
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An effective N6-methyladenosine-related long non-coding RNA prognostic signature for predicting the prognosis of patients with bladder cancer.
    Ma T; Wang X; Meng L; Liu X; Wang J; Zhang W; Tian Z; Zhang Y
    BMC Cancer; 2021 Nov; 21(1):1256. PubMed ID: 34802433
    [TBL] [Abstract][Full Text] [Related]  

  • 49. LncRNA CCND2-AS1 promotes proliferation, migration, and invasion in papillary thyroid carcinoma.
    Xia E; Bhandari A; Shen Y; Zhou X; Sindan N; Xiang J; Guan Y; Yang F; Wang O
    Biochem Biophys Res Commun; 2018 Feb; 496(2):628-632. PubMed ID: 29366479
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.
    Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W
    Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification and validation of endocrine resistance-related and immune-related long non-coding RNA (lncRNA) signatures for predicting endocrinotherapy response and prognosis in breast cancer.
    Yang M; Sun Y; Ji H; Zhang Q
    Ann Transl Med; 2022 Dec; 10(24):1399. PubMed ID: 36660659
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A prognostic signature based on the expression profile of the ferroptosis-related long non-coding RNAs in hepatocellular carcinoma.
    Lin X; Yang S
    Adv Clin Exp Med; 2022 Oct; 31(10):1099-1109. PubMed ID: 35581934
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel prognostic model for papillary thyroid cancer based on epithelial-mesenchymal transition-related genes.
    Liu R; Cao Z; Pan M; Wu M; Li X; Yuan H; Liu Z
    Cancer Med; 2022 Dec; 11(23):4703-4720. PubMed ID: 35608185
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An innovative pyroptosis-related long-noncoding-RNA signature predicts the prognosis of gastric cancer
    Xiong S; Jin L; Zeng C; Ma H; Xie L; Liu S
    Pathol Oncol Res; 2022; 28():1610712. PubMed ID: 36567977
    [No Abstract]   [Full Text] [Related]  

  • 55. Identification of Long Non-Coding RNA Expression Profiles and Co-Expression Genes in Thyroid Carcinoma Based on The Cancer Genome Atlas (TCGA) Database.
    Zhang Y; Jin T; Shen H; Yan J; Guan M; Jin X
    Med Sci Monit; 2019 Dec; 25():9752-9769. PubMed ID: 31856144
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The development and validation of a novel senescence-related long-chain non-coding RNA (lncRNA) signature that predicts prognosis and the tumor microenvironment of patients with hepatocellular carcinoma.
    Huang E; Ma T; Zhou J; Ma N; Yang W; Liu C; Hou Z; Chen S; de Castria TB; Zeng B; Zong Z; Zhou T
    Ann Transl Med; 2022 Jul; 10(14):766. PubMed ID: 35965795
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.
    Peng Y; Wang H; Huang Q; Wu J; Zhang M
    J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of immune-related lncRNAs to improve the prognosis prediction for patients with papillary thyroid cancer.
    Li Z; Lin W; Zheng J; Hong W; Zou J; Zhang T; Chen Y; Lu H
    Biosci Rep; 2021 Feb; 41(2):. PubMed ID: 33554245
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genome-wide analysis of long noncoding RNA expression profile in papillary thyroid carcinoma.
    Lan X; Zhang H; Wang Z; Dong W; Sun W; Shao L; Zhang T; Zhang D
    Gene; 2015 Sep; 569(1):109-17. PubMed ID: 26003293
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of Hub lncRNAs Along With lncRNA-miRNA-mRNA Network for Effective Diagnosis and Prognosis of Papillary Thyroid Cancer.
    Li H; Liu F; Wang X; Li M; Li Z; Xie Y; Guo Y
    Front Pharmacol; 2021; 12():748867. PubMed ID: 34721037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.